Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × Ketorolac Tromethamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain, Postoperative 2 Carcinoma, Renal Cell 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Kidney Neoplasms 1 Ileus 1 Fallopian Tube Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Curative Breast Cancer Surgery 1 Constipation 1 Colonic Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Agnosia 1 Acute Pain 1

Interventions

aldesleukin 38 Sunitinib 34 Cyclophosphamide 29 Nivolumab 27 pembrolizumab 25 Interferon-alpha 25 Everolimus 24 Sorafenib 20 fludarabine phosphate 19 Bevacizumab 19 Interleukin-2 17 Ipilimumab 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 Filgrastim 15 Radiotherapy 14 Axitinib 14 cabozantinib 13 temsirolimus 10 fludarabine 10 Radiosurgery 10 Doxorubicin 10 Carboplatin 10 sargramostim 8 belzutifan 8 Fluorouracil 8 Etoposide 8 Chemotherapy, Adjuvant 8 Magnetic Resonance Spectroscopy 7 Ifosfamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡